A new voluntary Medicare model starts in July, and it could save you $11,000 per year. But there are steps you need to take ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets ...

Are GLP-1 drugs prescribed for weight loss becoming too outsized a line item for continued coverage through the state ...

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...

A once-weekly injectable GIP/GLP-1 dual agonist conferred up to 22.5% weight loss at 48 weeks for adults with overweight or ...

Make your running for weight loss journey one that goes beyond the numbers.

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to sustain once treatment ends. Stopping treatment with weight loss medications is ...

Rapid Weight Loss Centers' 20-Year Approach to Real Food and Sustainable Results Shares Core Principles with Federal ...

Don’t let missteps throw you off your path to weight loss.

Low-income Californians who use Wegovy and similar medications for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead. California and other ...